Covidien (NYSE: COV), a leading global provider of healthcare products, today announced the worldwide launch of the SILS(TM) Stitch articulating suturing device for advanced laparoscopic surgery, including SILS(TM) single incision procedures. The SILS(TM) Stitch instrument expands the Company's SILS(TM) product offering as well as its endoscopic suturing portfolio, which includes the leading automated endosuturing product on the market today, the Endo Stitch(TM) instrument and reloads.
Business Wire press release available: http://www.businesswire.com/news/home/20100518005863/en/Covidien-Launches-SIL...
Link to this comment:
All Comments (0)